Formulation Screening

Formulation screening is a procedure that looks for the best medicine using a variety of tools and analytical techniques. Making a pharmaceutical formulation safer, more effective, logical, stable, usable, and cost-effective is the goal of Formulation Screening. The development and clinical testing of the late preparations may be accelerated by choosing the appropriate excipients, preparation processes, and preparation forms. For instance, using the right kind and number of excipients leads in the optimal content release of tablets or capsules, which is necessary to achieve high therapeutic efficacy. To deliver an effective therapy with the fewest adverse effects possible in particular therapeutic areas, such as cancer, formulation and excipient are essential development phases. Particularly in Specialised Therapeutic Fields like dermatology, cancer, or the brain, where it can facilitate tumour cell penetration or blood-brain barrier (BBB) crossing. Different drug delivery techniques are chosen and compared in terms of biodistribution and delivery during the Formulation Screening Phase. Ima Biotech has the ability to work directly with the solution you've chosen to compare the effectiveness of API distribution and penetration (in combination with a few CDMO partners). By fusing molecular imaging, histology, and data science, we created a novel method for establishing penetration profiles and/or biodistribution maps in the tissue microenvironment. The best formulation is chosen in conjunction with our drug exposure and pharmacology services using a set of criteria.